Auroempa L 25/5 mg Tablet

Composition of Auroempa L 25/5 mg Tablet

Auroempa L 25/5 mg Tablet contains Empagliflozin 25 mg + Linagliptin 5 mg tablet. It belongs to the SGLT2 inhibitor + DPP-4 inhibitor combination class of medicines.

Uses of Auroempa L 25/5 mg Tablet

Type 2 diabetes mellitus: adjunct to diet and exercise to improve glycaemic control in adults when dual therapy is appropriate (including patients inadequately controlled on either component).

Key benefits

• Lowers HbA1c and fasting/postprandial glucose
• Once-daily dual therapy for type 2 diabetes
• Low intrinsic risk of hypoglycaemia (unless with insulin/SU)
• May aid modest weight reduction and lower blood pressure (empagliflozin component)

How Auroempa L 25/5 mg Tablet works

Empagliflozin is an SGLT2 inhibitor that lowers blood sugar by increasing urinary glucose excretion via the kidneys. Linagliptin is a DPP-4 inhibitor that increases incretin hormones, enhancing insulin release and reducing glucagon secretion in a glucose-dependent manner.

How to take Auroempa L 25/5 mg Tablet

Oral tablet. Usually taken once daily, with or without food, at the same time each day. Swallow whole with water; do not crush unless advised. Dose and duration as prescribed by a doctor; continue diet/exercise and regular glucose monitoring.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.

If you take too much

An overdose of this medicine can cause dehydration and a fall in blood pressure. It may cause low blood sugar, particularly if you also take other diabetes medicines. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Auroempa L 25/5 mg Tablet

Most side effects of Auroempa L 25/5 mg are mild and settle as the body adjusts. Reported side effects include:

• Increased urination
• thirst
• genital fungal infection
• urinary tract infection
• nasopharyngitis
• headache
• dizziness
• nausea
• rash
• hypoglycaemia (especially with insulin/sulfonylurea)

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Auroempa L 25/5 mg Tablet

Warnings and precautions

Not for type 1 diabetes or diabetic ketoacidosis. Risk of dehydration/low blood pressure and acute kidney injury—maintain fluids; caution in elderly, diuretics, low BP, kidney disease. May increase risk of genital mycotic infections and UTIs; seek care for fever, flank pain, painful urination. Stop and seek urgent care if symptoms of ketoacidosis occur (nausea/vomiting, abdominal pain, rapid breathing) even if sugars are not very high. Rare risk of pancreatitis (persistent severe abdominal pain) and hypersensitivity with linagliptin. Temporarily withhold before major surgery/serious illness or prolonged fasting as advised. Kidney function should be assessed before and during therapy; not recommended in severe renal impairment/ESRD.

Do not take Auroempa L 25/5 mg if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for type 1 diabetes or for diabetic ketoacidosis. Not for people with severe kidney disease.

Interactions with other medicines

Insulin and sulfonylureas (increased hypoglycaemia risk), diuretics (increased dehydration/hypotension risk), lithium (possible level changes with SGLT2 inhibitors), strong CYP3A4/P-gp inducers e.g., rifampicin, carbamazepine, phenytoin, phenobarbital, St John’s wort (may reduce linagliptin effect)

How to store Auroempa L 25/5 mg Tablet

Store below 25°C in a cool, dry place. Protect from moisture and direct light. Keep in original blister pack and out of reach of children.

Expert advice for Auroempa L 25/5 mg Tablet

Take it in the morning so the extra urine does not disturb your sleep. Keep up your fluid intake and maintain genital hygiene. Tell any doctor treating you for an acute illness that you take this medicine. It can be taken with or without food, at the same time each day. Keep up your diet and activity — this medicine supports them.

Manufacturer and class

Manufacturer:

VEITAZ HEALTHCARE LIMITED

Therapeutic class:

Antidiabetic

Drug class:

SGLT2 inhibitor + DPP-4 inhibitor combination